Document is current
Any future updates will be listed below
-
Authors
Pickles, Sarah
Gendron, Tania F.
Koike, Yuka
Yue, Mei
Song, Yuping
Kachergus, Jennifer M.
Shi, J.
DeTure, Michael
Thompson, E. Aubrey
Oskarsson, Björn
Graff-Radford, Neill R.
Boeve, Bradley F.
Petersen, Ronald C.
Wszolek, Zbigniew K.
Josephs, Keith A.
Dickson, Dennis W.
Petrucelli, Leonard
Cook, Casey N.
Prudencio, Mercedes https://orcid.org/0000-0002-4894-4858
-
Funding
Funding for this research was provided by:
NINDS (R35NS097273)
NIH (U54NS123743, P01NS084974, RF1NS120992, R01AG37491, R01AG063780)
Robert Packard Center for ALS Research, Johns Hopkins University
Milton Safenowitz Postdoctoral Fellowship Program (21-PDF-582)
BrightFocus Foundation (A2020279F)
Donald G. and Jodi P. Herringa Family
- License Information
-
More Information
Article History
Received: 16 May 2022
Accepted: 11 July 2022
First Online: 25 July 2022
Declarations
:
: All participants or their family members gave written informed consent, and all protocols were approved by the Mayo Clinic Institution Review Board and Ethics Committee.
: Not applicable.
: MP serves as a consultant for Target ALS. LP serves as a consultant for Expansion Therapeutics. LP has licensing agreements for frontotemporal dementia mouse models and antibodies. ZKW is partially supported by the NIH/NIA and NIH/NINDS (1U19AG063911, FAIN: U19AG063911), Mayo Clinic Center for Regenerative Medicine, a gift from the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases fund, and The Albertson Parkinson's Research Foundation. ZKW serves as PI or Co-PI on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), Neuraly, Inc. (NLY01-PD-1), and Vigil Neuroscience, Inc. (VGL101-01.001 and VGL101-01.002) grants. ZKW serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research and as an external advisory board member for the Vigil Neuroscience, Inc. BO serves as a consultant for Columbia University/Tsumura Inc, MediciNova, and Mitsubishi and have research grants from Columbia University/Tsumura Inc, Biogen, MediciNova, Cytokinetics, Mitsubishi, Calico, and Target ALS.
